Skip to main content
RAPS Euro Convergence 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Learning Level: Advanced
Learning Level: Advanced
Learning Level: Expert
Learning Level: Expert
Learning Level: Foundational
Learning Level: Foundational
Learning Level: Intermediate
Learning Level: Intermediate
RAPS Focus
RAPS Focus
Networking Opportunity
Networking Opportunity
Ticketed Event
Ticketed Event
Student Focus
Student Focus

Adrien Marchand (he/him/his)

Principal Consultant
Lucendra SA
Mont-sur-Rolle, Vaud, Switzerland

Adrien Marchand is a Principal Consultant and Subject Matter Expert in Scientific Affairs at Lucendra SA, bringing more than a decade of experience at the interface of science, regulation, and medical technology. With a strong foundation in analytical chemistry and a PhD in Chemistry–Biology Interface from the University of Bordeaux, he has built a career dedicated to advancing the safe and effective development of medical devices.

Adrien has 10 years of expertise in scientific method development and more than 5 years of consultancy experience in the MedTech sector, where he specializes in biocompatibility and toxicological risk assessment. He supports clients in identifying chemical and biological risks, defining pragmatic testing strategies, and interpreting results in compliance with international standards, including ISO 10993 and ISO 18562 series. His work also encompasses cleaning and sterilization validation for novel and reusable devices, as well as regulatory strategies for substance-based products.

Throughout his career, Adrien has collaborated closely with Regulatory Authorities, ensuring robust scientific and regulatory arguments to support successful submissions under the EU Medical Device and In Vitro Diagnostic Regulations. His expertise extends across toxicological risk assessment, quality management systems, and risk management, making him a trusted advisor to manufacturers navigating complex regulatory pathways.

His background includes a research fellowship at ETH Zürich, where he focused on developing advanced mass spectrometry methods. This scientific training, combined with consultancy experience, equips him with both technical depth and strategic insight, enabling him to bridge the perspectives of chemists, toxicologists, and regulators. Passionate about fostering clarity in regulatory science, Adrien is committed to promoting effective practices in biological evaluation and toxicological assessment to improve patient safety and regulatory consistency.

Presentation(s):